SCHEMBL6339917

SCHEMBL6339917

O=[N+]([O-])c1ccc2c([N+](=O)[O-])c(O)c(O)cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 2/20 0.58
▸ COMT P21964 1/20 0.48
▸ GPR35 Q9HC97 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ TSHR P16473 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ PTGS2 P35354 1/20 0.45
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ ERN1 O75460 1/20 0.44
▸ TDP1 Q9NUW8 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TTR P02766 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7909511 0.81 ESR1 (0.65) S100A4GPR35ALDH1A1HPGDMAPK1
SCHEMBL6339929 0.80 S100A4 (0.55) S100A4ALDH1A1SMN1; SMN2ERN1TDP1
SCHEMBL6345493 0.80 COMT (0.48) S100A4COMTTSHRTP53GAA
SCHEMBL11856095 0.80 ERN1 (0.51) S100A4GPR35ALDH1A1HPGDMAPK1
SCHEMBL6349986 0.79 CYP3A4 (0.67) S100A4COMTGPR35ALDH1A1TSHR
SCHEMBL6348505 0.77 S100A4 (0.48) S100A4ALDH1A1MAPK1SMN1; SMN2TDP1
SCHEMBL17233510 0.77 CYP3A4 (0.53) S100A4COMTGPR35TSHRTHRB
SCHEMBL6340090 0.76 MEN1 (0.50) S100A4COMTALDH1A1MAPK1SMN1; SMN2
SCHEMBL6340091 0.76 MEN1 (0.50) S100A4COMTALDH1A1MAPK1SMN1; SMN2
SCHEMBL6339877 0.75 COMT (0.47) S100A4COMTALDH1A1HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903114-B2 Derivatives of naphthalene with COMT inhibiting activity ORION CORPORATION (FI) 2005-06-07 — — US disclosed
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity ORION CORPORATION (FI) 2004-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034011-A1 Derivatives of naphthalene with comt inhibiting activity COMT, CYP1A1, CYP1B1 S100A4 4776/4885COMT 1/4885GPR35 2904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback